Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders

KJ Falkenberg, RW Johnstone - Nature reviews Drug discovery, 2014 - nature.com
Epigenetic aberrations, which are recognized as key drivers of several human diseases, are
often caused by genetic defects that result in functional deregulation of epigenetic proteins …

[HTML][HTML] Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs

HJ Kim, SC Bae - American journal of translational research, 2011 - ncbi.nlm.nih.gov
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that
play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis …

Anticancer activities of histone deacetylase inhibitors

JE Bolden, MJ Peart, RW Johnstone - Nature reviews Drug discovery, 2006 - nature.com
Histone deacetylases (HDACs) are enzymes involved in the remodelling of chromatin, and
have a key role in the epigenetic regulation of gene expression. In addition, the activity of …

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

PA Marks, R Breslow - Nature biotechnology, 2007 - nature.com
In our quest to understand why dimethyl sulfoxide (DMSO) can cause growth arrest and
terminal differentiation of transformed cells, we followed a path that led us to discover …

Resistance to trastuzumab in breast cancer

PR Pohlmann, IA Mayer, R Mernaugh - Clinical cancer research, 2009 - AACR
HER2 is a transmembrane oncoprotein encoded by the HER2/neu gene and is
overexpressed in approximately 20 to 25% of invasive breast cancers. It can be …

Acetylation of non-histone proteins modulates cellular signalling at multiple levels

S Spange, T Wagner, T Heinzel, OH Krämer - The international journal of …, 2009 - Elsevier
This review focuses on the posttranslational acetylation of non-histone proteins, which
determines vital regulatory processes. The recruitment of histone acetyltransferases and …

Emerging role of PI3K/AKT in tumor-related epigenetic regulation

Q Yang, W Jiang, P Hou - Seminars in Cancer biology, 2019 - Elsevier
Epigenetic alterations, along with genetic alterations, have long been regarded as the most
important mechanism participating in carcinogenesis. DNA methylation, histone …

[HTML][HTML] Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone …

P Bali, M Pranpat, J Bradner, M Balasis… - Journal of Biological …, 2005 - ASBMB
The hydroxamic acid (HAA) analogue pan-histone deacetylase (HDAC) inhibitors (HDIs)
LAQ824 and LBH589 have been shown to induce acetylation and inhibit the ATP binding …

[图书][B] Anticancer agents from natural products

GM Cragg, DGI Kingston, DJ Newman - 2005 - taylorfrancis.com
Plants, marine organisms, and microorganisms have evolved complex chemical defense
and signaling systems that are designed to protect them from predators and provide other …

Discovery and development of SAHA as an anticancer agent

PA Marks - Oncogene, 2007 - nature.com
The path to the discovery of suberoylanilide hydroxamic acid (SAHA, vorinostat) began over
three decades ago with our studies designed to understand why dimethylsulfoxide causes …